(Q40177590)

18 September 2017

title

CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells (English)

1 reference

18 September 2017

1 reference

Casey W Wright

1

1 reference

18 September 2017

Julie M Rumble

series ordinal

2

1 reference

18 September 2017

Colin S Duckett

series ordinal

3

1 reference

18 September 2017

language of work or name

English

0 references

publication date

29 January 2007

1 reference

Journal of Biological Chemistry

18 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 September 2017

volume

282

1 reference

18 September 2017

issue

14

1 reference

18 September 2017

page(s)

10252-10262

1 reference

CD30 in normal and neoplastic cells.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

The TNF receptor family member CD30 is not essential for negative selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

CD30-mediated signaling promotes the development of human T helper type 2-like T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

The TNF and TNF receptor superfamilies: integrating mammalian biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Involvement of CRAF1, a relative of TRAF, in CD40 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Shaping the nuclear action of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Specific protection against breast cancers by cyclin D1 ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608817200

21 January 2018

Identifiers

DOI

10.1074/JBC.M608817200

1 reference

18 September 2017

1 reference